TOKYO -- Japan looks to begin distribution of COVID-19 vaccines by the March end of the fiscal year as clinical trials on a number of candidates move forward.
A Japanese trial of U.S.-based Moderna's vaccine candidate is expected to begin soon. Japan's Takeda Pharmaceutical is responsible for handling the approval application here, as well as sales and distribution.
